Federal contract award
75N93020C00017
TO IDENTIFY AND DEVELOP A NON-BETA-LACTAM PBP INHIBITOR (NBP) WITH BROAD SPECTRUM OF ACTIVITY AGAINST MDR GRAM-NEGATIVE ESKAPE PATHOGENS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $5.6M |
| Current contract value | $5.6M |
| Potential contract value / ceiling | $15.3M |
| Start date | Jul 1, 2020 |
| Current end date | Dec 31, 2022 |
| Potential end date | Dec 31, 2022 |
| Latest award activity | Aug 18, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 18, 2026 | P00009 | $-245.7K | TO ADMINISTRATE DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| Sep 23, 2025 | P00008 | $-13.9K | TO IDENTIFY AND DEVELOP A NON-BETA-LACTAM PBP INHIBITOR (NBP) WITH BROAD SPECTRUM OF ACTIVITY AGAINST MDR GRAM-NEGATIVE ESKAPE PATHOGENS. |
| Mar 13, 2023 | P00007 | $0 | TO IDENTIFY AND DEVELOP A NON-BETA-LACTAM PBP INHIBITOR (NBP) WITH BROAD SPECTRUM OF ACTIVITY AGAINST MDR GRAM-NEGATIVE ESKAPE PATHOGENS. |
| Sep 19, 2022 | P00006 | $0 | TO IDENTIFY AND DEVELOP A NON-BETA-LACTAM PBP INHIBITOR (NBP) WITH BROAD SPECTRUM OF ACTIVITY AGAINST MDR GRAM-NEGATIVE ESKAPE PATHOGENS. |
| Apr 29, 2022 | P00005 | $0 | TO IDENTIFY AND DEVELOP A NON-BETA-LACTAM PBP INHIBITOR (NBP) WITH BROAD SPECTRUM OF ACTIVITY AGAINST MDR GRAM-NEGATIVE ESKAPE PATHOGENS. |
| Mar 9, 2022 | P00004 | $0 | TO IDENTIFY AND DEVELOP A NON-BETA-LACTAM PBP INHIBITOR (NBP) WITH BROAD SPECTRUM OF ACTIVITY AGAINST MDR GRAM-NEGATIVE ESKAPE PATHOGENS. |
| Jul 21, 2021 | P00003 | $2.9M | TO IDENTIFY AND DEVELOP A NON-BETA-LACTAM PBP INHIBITOR (NBP) WITH BROAD SPECTRUM OF ACTIVITY AGAINST MDR GRAM-NEGATIVE ESKAPE PATHOGENS. |
| Mar 25, 2021 | P00002 | $0 | TO IDENTIFY AND DEVELOP A NON-BETA-LACTAM PBP INHIBITOR (NBP) WITH BROAD SPECTRUM OF ACTIVITY AGAINST MDR GRAM-NEGATIVE ESKAPE PATHOGENS. |
| Sep 21, 2020 | P00001 | $0 | TO IDENTIFY AND DEVELOP A NON-BETA-LACTAM PBP INHIBITOR (NBP) WITH BROAD SPECTRUM OF ACTIVITY AGAINST MDR GRAM-NEGATIVE ESKAPE PATHOGENS. |
| Jun 29, 2020 | 0 | $3.0M | TO IDENTIFY AND DEVELOP A NON-BETA-LACTAM PBP INHIBITOR (NBP) WITH BROAD SPECTRUM OF ACTIVITY AGAINST MDR GRAM-NEGATIVE ESKAPE PATHOGENS. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.